* GeneReview / NIH / UW entry on Glycogen Storage Disease Type V

Action of Glycogen Phosphorylase on Glycogen

* GeneReview / NIH / UW entry on Glycogen Storage Disease Type II ( Pompe Disease )

Action of Glycogen Phosphorylase on Glycogen

Glycogen phosphorylase can act only on linear chains of glycogen ( α1-4 glycosidic linkage ).

R and T States of Glycogen Phosphorylase b Tower Helices, on the left and right respectively.

* GeneReviews / NCBI / NIH / UW entry on Glycogen Storage Disease Type VI-Hers disease

* GeneReview / NIH / UW entry on Glycogen Storage Disease Type I

However, PP-1 needs other proteins like PTG ( Protein Targeted to Glycogen ) to assist.

Glycogen storage disease ( GSD, also glycogenosis and dextrinosis ) is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types.

* Glycogen storage disease ( versus other storage disorders );

Glycogen is a complex carbohydrate, 65 % of which is stored in skeletal muscles and the remainder, in the liver ( totaling about 2, 000 kcal in the whole body ).

Glycogen is made primarily by the liver and the muscles, but can also be made by glycogenesis within the brain and stomach.

Glycogen is the analogue of starch, a glucose polymer in plants, and is sometimes referred to as animal starch, having a similar structure to amylopectin but more extensively branched and compact than starch.

Glycogen is a polymer of α ( 1 → 4 ) glycosidic bonds linked, with α ( 1 → 6 )- linked branches.

Glycogen is found in the form of granules in the cytosol / cytoplasm in many cell types, and plays an important role in the glucose cycle.

Glycogen forms an energy reserve that can be quickly mobilized to meet a sudden need for glucose, but one that is less compact than the energy reserves of triglycerides ( lipids ).

Glycogen is composed of a branched chain of glucose residues.

Glycogen storage disease type V ( GSD-V ) is a metabolic disorder, more specifically a glycogen storage disease, caused by a deficiency of myophosphorylase.

Glycogen is a multibranched polysaccharide that serves as a form of energy storage in animals and fungi.

Glycogen is the analogue of starch, a glucose polymer in plants, and is sometimes referred to as animal starch, having a similar structure to amylopectin but more extensively branched and compact than starch.

Glycogen is found in the form of granules in the cytosol / cytoplasm in many cell types, and plays an important role in the glucose cycle.

Glycogen forms an energy reserve that can be quickly mobilized to meet a sudden need for glucose, but one that is less compact than the energy reserves of triglycerides ( lipids ).

Glycogen is a branched biopolymer consisting of linear chains of glucose residues with further chains branching off every ten glucoses or so.

Glycogen phosphorylase is the primary enzyme of glycogen breakdown.

Glycogen is also a suitable storage substance due to its insolubility in water, which means it does not affect the osmotistic levels and pressure of a cell.

Glycogen synthesis is, unlike its breakdown, endergonic.

Glycogen is synthesized from monomers of UDP-glucose by the enzyme glycogen synthase, which progressively lengthens the glycogen chain with ( α1 → 4 ) bonded glucose.

Glycogen is cleaved from the nonreducing ends of the chain by the enzyme glycogen phosphorylase to produce monomers of glucose-1-phosphate, which is then converted to glucose 6-phosphate by phosphoglucomutase.

Glycogen is broken down rapidly via glycogen phosphorylase into individual glucose units during intense exercise.

Glycogen serves as the secondary long-term energy storage in animal and fungal cells, with the primary energy stores being held in adipose tissue.

Glycogen is the principal storage carbohydrate found in animals and is extremely rare in plants.

Glycogen phosphorylase catalyzes the rate-limiting step in glycogenolysis in animals by releasing glucose-1-phosphate from the terminal alpha-1, 4-glycosidic bond.

Glycogen is the intramuscular storage form of glucose, used to generate energy quickly once intramuscular creatine stores are exhausted, producing lactic acid as a metabolic byproduct.

Glycogen is the intramuscular storage form of glucose, used to generate energy quickly once intramuscular creatine stores are exhausted, producing lactic acid as a metabolic byproduct.

Glycogen is left with one fewer glucose molecule, and the free glucose molecule is in the form of glucose-1-phosphate.

Glycogen in liver and ( to a lesser degree ) kidneys serves as a form of stored, rapidly accessible glucose, so that the blood glucose level can be maintained between meals.

Glycogen stores are maximal at term, but even then, the fetus only has enough glycogen available to meet energy needs for 8 – 10 hours, which can be depleted even more quickly if demand is high.

Glycogen stores are the first to be broken down as they can easily yield glucose molecules, which is the body's preferred energy source.

Glycogen, a fuel used by muscles for energy, is depleted during work and restocked when a horse rests.

* Glycogen storage disease-McArdle's Disease Website

In an experiment directed by John C. Fyfea, Rebeccah L. Kurzhals, and others, it was concluded that a complex rearrangement in the breed's Glycogen branching enzyme ( GBE1 ) can cause both a perinatal hypoglycemic collapse and a late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV in the breed.

* Glycogen storage disease

* Glycogen storage disease type II, also called Pompe disease

* Glycogen storage disease ( type 1 )

Due to the heavy influx of American Quarter Horse breeding, some Paints may also carry genetic disorders such as Hyperkalemic Periodic Paralysis ( HYPP ), Hereditary Equine Regional Dermal Asthenia ( HERDA ), Equine polysaccharide storage myopathy ( called PSSM-polysaccharide storage myopathy-in Paints, Quarter Horses and Appaloosas ), Malignant hyperthermia ( MH ) and Glycogen Branching Enzyme Deficiency ( GBED ).

Also, Glycogen storage disease type II ( Pompe disease ) is also a defect in lysosomal metabolism, although it is otherwise classified into E74. 0 in ICD-10.

* Glycogen storage disease type 1.

* Glycogen storage disease

* Glycogen storage disease type II, or Pompe disease

Glycogen storage disease type II ( also called Pompe disease or acid maltase deficiency ) is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body.

Glycogen storage disease type II has an autosomal recessive pattern of inheritance.

simple: Glycogen storage disease type II

Phosphofructokinase deficiency, also known as Glycogen storage disease type VII or Tarui's disease, is metabolic disorder with autosomal recessive inheritance.

Glycogen storage disease type VII